Acute Pain Crisis Caused by Tramadol Remdesivir Drug-Drug Interaction.
COVID-19
SARS-CoV-2
pain crisis
palliative care
remdesivir
tramadol
Journal
Journal of palliative medicine
ISSN: 1557-7740
Titre abrégé: J Palliat Med
Pays: United States
ID NLM: 9808462
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
pubmed:
22
6
2021
medline:
7
10
2021
entrez:
21
6
2021
Statut:
ppublish
Résumé
Drug interactions are common and can affect patient outcomes. Drugs that undergo emergency approval have less preapproval drug testing to identify potential interactions. Tramadol is an effective pain medication prodrug with a complex mechanism of action that requires extensive metabolism. Remdesivir is an antiviral medication given emergency approval to treat hospitalized patients with COVID-19 infections. Remdesivir is also a nucleotide analogue prodrug that undergoes intracellular metabolic conversions to its active metabolite. We discuss the case of a hospitalized patient in the United States diagnosed with COVID-19 pneumonia who developed acute pain crisis secondary to a drug-drug interaction between tramadol and remdesivir, and we propose a possible mechanism of interaction.
Identifiants
pubmed: 34152842
doi: 10.1089/jpm.2021.0123
doi:
Substances chimiques
Pharmaceutical Preparations
0
Tramadol
39J1LGJ30J
remdesivir
3QKI37EEHE
Adenosine Monophosphate
415SHH325A
Alanine
OF5P57N2ZX
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM